Q1 2025 · 13F-HR
PFIZER INC (PFE)holdings as filed
Filed 2025-05-13 · accession 0000078003-25-000118
$500.8M
Reported value
21
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 09075V102 | BNTX | BIONTECH SE | $333.1M | 66.5% | 3,658,361 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $32.2M | 6.42% | 22,032,040 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $30.0M | 5.99% | 5,376,344 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $24.3M | 4.85% | 3,457,815 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $19.4M | 3.86% | 1,272,214 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $15.2M | 3.02% | 1,875,000 | Common | SHARED |
| G1110E107 | BHVN | BIOHAVEN LTD | $12.2M | 2.43% | 505,645 | Common | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $7.6M | 1.51% | 2,411,575 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $6.9M | 1.38% | 7,032,770 | Common | SOLE |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $4.3M | 0.86% | 4,690,431 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $3.8M | 0.76% | 2,970,022 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $3.5M | 0.71% | 349,406 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $2.6M | 0.53% | 1,675,000 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $1.7M | 0.34% | 2,362,348 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $1.5M | 0.30% | 953,834 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $972,801 | 0.19% | 715,295 | Common | SHARED |
| 65343E108 | NXTCEUR | NEXTCURE INC | $908,614 | 0.18% | 1,891,763 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $458,332 | 0.09% | 277,777 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $250,444 | 0.05% | 626,109 | Common | SHARED |
| 81727U105 | SENS1GBP | SENSEONICS HLDGS INC | $28,492 | 0.01% | 43,426 | Common | SHARED |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS INC | $16,690 | 0.00% | 2,928 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.